Metraipolis › archive › dc_3bf1a06ff66f

The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs — Europe PMC PMID:41303291

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41303291
DOI
10.3390/jcm14228247
License (as archived)
solo-consultazione
Archived
2026-11-08T09:38:30.515Z
SHA-256 of the archived text
fbf0a37a7913e9ad02e81649ce1c2cdd0cbfbc823f9c8465217f1d4fecbecbe6
Stable URL of this page
https://metraipolis.com/documento/dc_3bf1a06ff66f

How to cite

The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs — Europe PMC PMID:41303291 — Europe PMC (en), https://europepmc.org/article/MED/41303291 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3bf1a06ff66f (Metraipolis archive dc_3bf1a06ff66f, sha256 fbf0a37a7913e9ad02e81649ce1c2cdd0cbfbc823f9c8465217f1d4fecbecbe6)
BibTeX
@misc{dc3bf1a06ff66f,
  title = {The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs — Europe PMC PMID:41303291},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41303291},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3bf1a06ff66f; sha256 fbf0a37a7913e9ad02e81649ce1c2cdd0cbfbc823f9c8465217f1d4fecbecbe6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41303291. Agents can read the archived copy with the MCP tool read_document.